SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:145814894"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:145814894" > Higher sRAGE Levels...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002838naa a2200349 4500
001oai:prod.swepub.kib.ki.se:145814894
003SwePub
008240701s2021 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1458148942 URI
024a https://doi.org/10.1159/0005122872 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Butcher, L4 aut
2451 0a Higher sRAGE Levels Predict Mortality in Frail Older Adults with Cardiovascular Disease
264 c 2021-01-21
264 1b S. Karger AG,c 2021
520 a <b><i>Introduction:</i></b> The evidence that blood levels of the soluble receptor for advanced glycation end products (sRAGE) predict mortality in people with cardiovascular diseases (CVD) is inconsistent. To clarify this matter, we investigated if frailty status influences this association. <b><i>Methods:</i></b> We analysed data of 1,016 individuals (median age, 75 years) from 3 population-based European cohorts, enrolled in the FRAILOMIC project. Participants were stratified by history of CVD and frailty status. Mortality was recorded during 8 years of follow-up. <b><i>Results:</i></b> In adjusted Cox regression models, baseline serum sRAGE was positively associated with an increased risk of mortality in participants with CVD (HR 1.64, 95% CI 1.09–2.49, <i>p</i> = 0.019) but not in non-CVD. Within the CVD group, the risk of death was markedly enhanced in the frail subgroup (CVD-F, HR 1.97, 95% CI 1.18–3.29, <i>p</i> = 0.009), compared to the non-frail subgroup (CVD-NF, HR 1.50, 95% CI 0.71–3.15, <i>p</i> = 0.287). Kaplan-Meier analysis showed that the median survival time of CVD-F with high sRAGE (&#x3e;1,554 pg/mL) was 2.9 years shorter than that of CVD-F with low sRAGE, whereas no survival difference was seen for CVD-NF. Area under the ROC curve analysis demonstrated that for CVD-F, addition of sRAGE to the prediction model increased its prognostic value. <b><i>Conclusions:</i></b> Frailty status influences the relationship between sRAGE and mortality in older adults with CVD. sRAGE could be used as a prognostic marker of mortality for these individuals, particularly if they are also frail.
700a Carnicero, JA4 aut
700a Peres, K4 aut
700a Colpo, M4 aut
700a Cabrero, DG4 aut
700a Dartigues, JF4 aut
700a Bandinelli, S4 aut
700a Garcia-Garcia, FJ4 aut
700a Rodriguez-Manas, L4 aut
700a Erusalimsky, JD4 aut
773t Gerontologyd : S. Karger AGg 67:2, s. 202-210q 67:2<202-210x 1423-0003x 0304-324X
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:145814894
8564 8u https://doi.org/10.1159/000512287

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view